Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Policy: NIH to balance sex in cell and animal studies.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
Interferon-beta1b for the treatment of multiple sclerosis.
UCSF Seminar: "Imaging spinal cord gray matter atrophy in MS using SF-SIGMA. Is neuronal loss a key mediator of MS disability?"
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Measuring participation as defined by the World Health Organization in the International Classification of Functioning, Disability and Health. Psychometric properties of the Ghent Participation Scale.
Drugs@FDA
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
Autoimmune myelopathies.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
[Prevalence of multiple sclerosis in the Region of Murcia].
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.
New data from Phase 3 studies provide additional evidence supporting treatment effect for oral BG-12 (dimethyl fumarate) in multiple sclerosis
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
UCSF Seminar: "MRI of Lesion Development and Repair in Multiple Sclerosis"
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Atypical facial pain in multiple sclerosis caused by spinal cord seizures: a case report and review of the literature.
Effects of dimethyl fumarate on lymphocyte subsets.

Pages